An epithelial cell line (BALB/c-ST) was established from a mammary adenocarcinoma that developed spontaneously in a 20-month-old BALB/c mouse. Like uninfected normal tissues, the cell line was found to contain three endogeneous murine mammary tumor virus (MuMTV) proviruses, but MuMTV particles and antigens were not detected. The cultured cells, after being inoculated subcutaneously, produced tumors in syngeneic mice, and sera from a high percentage of the tumor-bearing mice specifically immunoprecipitated an 86-kilodalton antigen from the extracts of BALB/c-ST cells. This antigen was found to be glycosylated, but whether or not it was exposed to the cell surface could not be demonstrated by cell-surface iodination and immunoprecipitation studies. The 86-kilodalton antigen, a glycoprotein designated gp86, was not detected in immunoprecipitates from extracts of normal mammary cells or from the extracts of GR, C3H, and BALB/cfC3H mammary tumor cells. After being infected in vitro with RIII-derived MuMTV but not with C3H-derived MuMTV, the BALB/c-ST cells appeared to undergo a phenotypic change in that they did not produce tumors in syngeneic mice, and the expression of gp86 was inhibited. Our results indicate that the expression of gp86 in the mammary cells of BALB/c mice is a consequence of neoplastic transformation and that MuMTV infection modulates its expression.
mammary tumors develop between ages 16 and 30 months, and only 18% of these tumors are adenocarcinomas (1) . The murine mammary tumor virus (MuMTV) is known to be the etiological agent of spontaneous mammary adenocarcinomas in several strains of mice (2) . As a general rule, these tumors produce MuMTV particles and contain one or more additional MuMTV proviruses as compared to uninfected tissues (3) (4) (5) (6) (7) (8) . By contrast, several spontaneous mammary tumors of BALB/c mice that have been examined did not appear to contain MuMTV particles, enhanced expression of MuMTV RNA, or additional proviral sequences (6, 9, 10) . Thus, the role of MuMTV in the development of spontaneous mammary tumors, particularly adenocarcinomas, in BALB/c mice is unknown. Because of the low incidence of spontaneous mammary adenocarcinomas and lack of transplantable tumor or established cell lines derived from such tumors, investigations into the biology of such tumors have not been possible. To facilitate such studies, we established an epithelial cell line designated BALB/c-ST from a spontaneous BALB/c mammary adenocarcinoma. In this paper we report that this cell line contains only endogenous MuMTV proviruses but does not appear to produce MuMTV particles or proteins. However, unlike normal mammary cells, the BALB/c-ST cells were found to produce an 86-kilodalton (kDa) glycoprotein (gp86). We also report that after infection in vitro by MuMTV from RIII mice, the tumorigenic BALB/c-ST cells became nontumorigenic, and the expression of gp86 was inhibited. These results suggest that spontaneous mammary tumorigenesis in BALB/c mice results in the expression of a transformation-related antigen, gp86.
MATERIALS AND METHODS
Cell Culture. A spontaneous mammary adenocarcinoma that developed in a 20-month-old BALB/c mouse was used to establish a cell line designated BALB/c-ST. The tumor cells were dissociated by 0.25% trypsin in calcium-and magnesium-free saline (11, 12) , cellular debris and large aggregates of cells were allowed to sediment for several minutes, and the supernatant was centrifuged at 300 x g for 10 min. The resulting cell pellet was resuspended in Hanks-Eagle minimal essential medium (HE-ME medium) supplemented with 10% fetal calf serum and 10 jig of insulin per ml, and the cells were plated at a density of 1 x 106 cells per ml. At present the cells are at the 160th passage and are maintained in HE-ME medium supplemented with inactivated fetal calf serum (10%) penicillin (100 units/ml), streptomycin (100 ,ug/ml), insulin (10 ,tg/ml), and glutamine (2 mM).
Three other established mammary tumor cell lines-MuMT-73, GR-3A, and Mm5mt-and one established and another primary epithelial cell cultures-MG-EPI and BALB/c-MG (12) , which were derived from the mammary glands of a midpregnant and a lactating BALB/c mouse, respectively-were also used in this study. The source and the conditions for culturing the mammary tumor cell lines have been described (13) . The MG-EPI cell line was obtained from C. McGrath of the Michigan Cancer Foundation and was maintained in a medium similar to that used for the GR-3A cells.
Cell Aggregation Viability (CAV) Test. The CAV index of the BALB/c-ST cells was determined as described (12) . Briefly, 2 ml of 1% Bacto-agar (Difco) in HE-ME medium containing 10% fetal bovine serum was added to the wells (3.5 x 3.5 cm) of Costar plastic plates. Trypsinized cells resuspended in 2 ml of culture medium (105 cells per ml) were then added to the congealed agar and incubated at 37°C for 4 days under a 95% air/5% CO2 atmosphere, after which the number of viable cells present in the wells was determined by trypan blue dye exclusion. The CAV index is defined as the number of cells survived per number of cells plated.
Infection with MuMTV. The BALB/c-ST cells were infected with purified MuMTV as described (14) . Briefly, 1 x 106 cells were resuspended in HE-ME medium containing 4 ,ug of Polybrene per ml and about 1011 MuMTV particles from the milk of MuMTV-infected RIII or C3H mice, designated RITI-or C3H-MuMTV. After 1 hr at 37°C with intermittent agitation, the cell/virus suspension was diluted with complete medium and plated on culture flasks.
Abbreviations: MuMTV, murine mammary tumor virus; kDa, kilodalton(s); gp86, 86-kDa glycoprotein; CAV, cell aggregation viability; kb, kilobase(s).
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Test for the Tumorigenicity of BALB/c-ST Cells. BALB/c-ST cells grown to confluency were trypsinized, resuspended in regular growth medium, pelleted by low-speed centrifugation, and resuspended again in fresh medium or phosphatebuffered saline, and cell counts were taken. Four-to 6-wkold BALB/c mice were injected subcutaneously with 4-8 x 106 BALB/c-ST cells in 100-150 ,ul of ME medium or phosphate-buffered saline and observed for tumor development.
Preparation of Serum. Serum was obtained from the blood of 23 mice bearing BALB/c-ST cell-induced tumors measuring approximately 1-2 cm in diameter. Sera from 10 agematched normal BALB/c mice that were not inoculated with the cell line and sera from 5 RIII and 2 GR mice with spontaneous mammary tumors also were prepared. Anti-MuMTV antibody (13), reactive to the major envelope and core polypeptides of MuMTV, also was used in this study.
Immunofluorescence. Viable and acetone-fixed cells were examined for antigens with mouse and anti-MuMTV antisera by immunofluorescence tests as described (13) .
Electron Microscopy. Tumor tissues and cultured cells were examined by thin-section electron microscopy (11) .
Reverse Transcriptase Assay. The RNA-directed DNA polymerase assay was done with the synthetic template primer poly(rC)oligo(dG) in the presence of Mg2+ or Mn2+ as described (11 To determine if the BALB/c-ST cells were transformed and tumorigenic, we measured the CAV index of the cells. From repeated tests at various passage levels, we found that the CAV index ranged from 0.9 to 1.5, with an average value of 1.3. This is a high CAV index compared to that of normal mammary cells of both BALB/c (0.14-0.25) and C57BL (0.08-0.2) mice but is similar to those of the transformed phenotype of the BALB/c and C57BL mammary cells (12 detected by the sera might be specific to mammary tumor. In order to identify the antigen(s), extracts of BALB/c-ST cells labeled with [3S]methionine were immunoprecipitated with sera from tumor-bearing mice. The results with 7 of the 23 sera tested are shown in Fig. 2 , lanes d-j. Three of the 7 sera specifically and predominantly immunoprecipitated a protein of 86 kDa (p86) from the BALB/c-ST cell extracts (lanes e-g). The other 4 sera also immunoprecipitated small amounts of p86. Small amounts of a low molecular mass 19-kDa protein (p19) also were found to be coprecipitated with p86 (lanes e-g). Of the 23 sera tested, 6 immunoprecipitated relatively large amounts of p86, 11 sera immunoprecipitated smaller amounts, and the remaining 6 sera were negative. Of the 6 sera that had high antibody reactivity to p86, only 3 sera immunoprecipitated p19. It should be pointed out that precipitation of p19 was found to be variable. For example, a particular serum demonstrated the precipitation of p19 from the extracts of BALB/c-ST cells in one experiment (Fig. 2 , lane f) but did not detect the antigen in another similar experiment (see Fig. 4, lane b) .
Neither p86 nor p19 was detected in the extracts of BALB/c-ST cells by sera from 10 normal BALB/c mice and by sera from 5 RIII and 2 GR mice bearing spontaneous mammary tumors. An example of the results obtained with one such serum is shown in lane b of Fig. 2 . Similarly, antiMuMTV antiserum, containing mainly the reactivity against the major envelope and core proteins (gp52 and p28, respectively) of the virus, failed to detect either p86 or p19 (Fig. 2,  lane c) . It should be mentioned that a number of proteins with molecular sizes between 35 and 70 kDa were often precipitated by sera from normal (Fig. 2, lane b) and tumorbearing (Fig. 2, lanes d-j) mice as well as by goat antiMuMTV antisera (Fig. 2, lane c) , suggesting nonspecific precipitation of these proteins.
In order to determine whether or not the expression of p86 and p19 is specific to the BALB/c-ST cells or if these proteins are expressed by normal mammary epithelial cells of the BALB/c mice, we compared the PAGE patterns of the immunoprecipitates obtained with sera from tumor-bearing mice, using the extracts of normal mammary gland cells of BALB/c mice and BALB/c-ST cells. It was found that neither the p86 nor the p19 protein was precipitated from normal BALB/c cells (Fig. 3, lanes d and e) but that the same serum precipitated p86 from the BALB/c-ST cells (Fig. 3 -j) , and the immunoprecipitates were analyzed by NaDodSO4/PAGE. The labeled proteins were detected by fluorography. Lane a contained marker proteins labeled with '4C-labeled amino acids; sizes are shown in kDa. The molecular mass of p19 protein was estimated by comparing its migration with respect to a number of small marker proteins. (Fig. 5, lanes b and c) ; neither of these glycoproteins was detected by serum from normal BALB/c mice (Fig. 5, lane a) . The same two sera used in this experiment also immunoprecipitated specifically the 86-kDa protein from the [35S]methionine-labeled BALB/c-ST cells (data not shown), suggesting that the 86-kDa protein is a glycoprotein. Repeated experiments with five different sera from tumor-bearing mice did not show the presence of p19 in the immunoprecipitates that were obtained from the extracts of glucosamine-labeled cells. It is likely, therefore, that p19 is not a glycoprotein. When the extracts of BALB/c-ST cells that were surface-labeled with 125I were immunoprecipitated with sera that had reactivity against gp86 and p19, the major polypeptide component detected in the immunoprecipitates was a 73-kDa (gp73) protein (Fig. 5, lanes e and f) . In addition, a small amount of p19 was also detected in some of the immunoprecipitates. These observations indicate that both gp73 and p19 are exposed to the cell surface, whereas the 86-kDa protein, although glycosylated, was either not exposed to the cell surface or not accessible to iodination.
Interaction of MuMTV with the BALB/c-ST Cells. Since the BALB/c-ST cells were tumorigenic in syngeneic mice but did not appear to produce MuMTV, we were interested in determining if these cells were susceptible to productive MuMTV infection and, if so, the effect that such an infection would have on the tumorigenicity of the cells. The BALB/c-ST cells were infected with RIII-and C3H-MuMTV, and after 2-3 wk the cells were examined for MuMTV production by electron microscopy, immunofluorescence, and reverse transcriptase assay. The tumorigenicity of the MuMTV-infected cells was determined by testing the ability of the cells to grow in BALB/c mice. It was found by specific membrane immunofluorescence, by visualization of both budding virus particles at the cell membrane and mature extracellular virus particles by electron microscopy, and by the detection of reverse transcriptase activity in the high-speed pellet of the cell-free culture supernatant that, after both C3H-and RIII-MuMTV infection, the BALB/c-ST cells produced MuMTV particles (data not shown). By membrane immunofluorescence, we estimated that almost all of the C3H-MuMTV-infected cells and about 80% of the RIII-MuMTVinfected cells were positive for the MuMTV antigen expres-
sion. Subsequent examination of the cells at various passage levels gave similar results, suggesting that the cells were productively and permanently infected with MuMTV.
Our investigations into the effect of MuMTV infection on the growth of the BALB/c-ST cells revealed striking differences between the C3H-MuMTV-and RIII-MuMTV-infected cells. The doubling time (22 hr) of the C3H-MuMTV-infected cells and their CAV index were found to be similar to those of the uninfected cells. Furthermore, the C3H-Mu-MTV-infected cells remained highly tumorigenic; 80-100% of the syngeneic BALB/c mice injected with 4-6 x 106 cells developed palpable mammary tumors within 3-4 wk ( Table  1) . By contrast, after infection with RIII-MuMTV, the growth rate of the BALB/c-ST cells dropped greatly (doubling time, 70 hr), the clonal growth in soft agar was inhibited, and, more importantly, BALB/c mice inoculated with the cells did not develop any tumors within the 6 months of observation ( Table 1 ). As this finding was so unexpected, the experiment was repeated twice in its entirety-from the initial infection of the cells with two different viral preparations to the tests for tumorigenicity. Each experiment confirmed the complete loss of tumorigenic phenotype of the BALB/c-ST cells upon infection with RIII-MuMTV.
Modulation of gp86 Expression in the BALB/c-ST Cells. As shown in Table 1 Our studies on the interaction of MuMTV with BALB/c-ST cells revealed an intriguing aspect of MuMTV infection. After infection with RIII-MuMTV, but not with C3H-MuMTV, the BALB/c-ST cells lose their tumorigenic potential and the expression of gp86 in these cells is inhibited. The mechanism by which RIII-MuMTV infection results in the loss of tumorigenicity of, and inhibition of gp86 synthesis in, BALB/c-ST cells is unknown. However, it is possible that RIII-MuMTV may have been integrated into the genome of most of the BALB/c-ST cells during infection in a region near or within the gene whose expression is associated with the induction of spontaneous mammary tumors in BALB/c mice, thereby causing a deletion or insertional mutation of that gene. Such a mutation could account for the loss of tumorigenic potential of the cells, and a possible consequence of this could be the inhibition of gp86 expression. Such a mechanism would be similar to that reported by Varmus and co-workers (17, 18) 
